Bedrosian Camille L 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Bedrosian Camille L（CIK 1326969）在 3 家公司共报告 12 笔 SEC Form 4 内部人交易（最近一笔 2026-09-14）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-14 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Medical Officer | 卖出 | 7,947 | $256,004 |
| 2026-09-14 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Medical Officer | 卖出 | 2,081 | $68,864 |
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | 董事 | 卖出 | 16,300 | $1.4M |
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | 董事 | 卖出 | 5,925 | $503,625 |
| 2026-08-20 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Medical Officer | 买入 | 22,807 | $0 |
| 2026-06-22 | Crinetics Pharmaceuticals, Inc. (CRNX) | 董事 | 买入 | 5,925 | $0 |
| 2026-03-09 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Medical Officer | 买入 | 95,990 | $0 |
| 2026-03-04 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Medical Officer | 卖出 | 6,461 | $94,201 |
| 2025-12-03 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Medical Officer | 卖出 | 6,580 | $94,423 |
| 2025-10-02 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Medical Officer | 卖出 | 12,039 | $175,529 |
| 2025-06-23 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | 董事 | 买入 | 4,000 | $0 |
| 2025-06-13 | Crinetics Pharmaceuticals, Inc. (CRNX) | 董事 | 买入 | 6,900 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-14